Cargando…
MT1-MMP-dependent ECM processing regulates laminB1 stability and mediates replication fork restart
Radiotherapy remains a mainstay of treatment for a majority of cancer patients. We have previously shown that the membrane bound matrix metalloproteinase MT1-MMP confers radio- and chemotherapy resistance to breast cancer via processing of the ECM and activation of integrinβ1/FAK signaling. Here, we...
Autores principales: | Thakur, Varsha, Tiburcio de Freitas, Juliano, Li, Yuan, Zhang, Keman, Savadelis, Alyssa, Bedogni, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266045/ https://www.ncbi.nlm.nih.gov/pubmed/34237080 http://dx.doi.org/10.1371/journal.pone.0253062 |
Ejemplares similares
-
MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility
por: Shaverdashvili, Khvaramze, et al.
Publicado: (2015) -
Argonaute2 and LaminB modulate gene expression by controlling chromatin topology
por: Nazer, Ezequiel, et al.
Publicado: (2018) -
Critical Role of Transient Activity of MT1-MMP for ECM Degradation in Invadopodia
por: Watanabe, Ayako, et al.
Publicado: (2013) -
Correction: Critical Role of Transient Activity of MT1-MMP for ECM Degradation in Invadopodia
por: Watanabe, Ayako, et al.
Publicado: (2013) -
Establishment and Validation of Computational Model for MT1-MMP Dependent ECM Degradation and Intervention Strategies
por: Hoshino, Daisuke, et al.
Publicado: (2012)